The Last Days Of Lipitor: Morass Of Regulatory, Legal Issues Could Mean Few Early Generics

Call it the Duragesic-ization or the Prevacid-ization, but not the Zocor-ization, of Lipitor.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet